South Plainfield, NJ -- December 7, 2011 -- GENEWIZ, Inc., leading global provider of DNA services, was honored by NJBIZ as the 2011 Business of the Year on Monday evening, December 5. The prestigious Business of the Year Award honors businesses and business leaders who have made significant contributions to the growth and development of New Jersey.
The Business of the Year Awards recognize excellence across six categories: Business of the Year (1-50 Employees); Business of the Year (51-100 Employees); Business of the Year (101+ Employees); Corporate Citizen of the Year; Executive of the Year; and Emerging Business of the Year.
Co-founders Dr. Steve Sun and Dr. Amy Liao accepted the Business of the Year Award (101+ Employees category) on behalf of GENEWIZ from David Schankweiler, CEO, Journal Publications Inc., and Thomas F. Curtin, Publisher, NJBIZ.
“We are thrilled about receiving this esteemed award,” commented Amy Liao, GENEWIZ President & COO. “The fact that NJBIZ recognizes not only our dedication to delivering value to customers, but also our commitment to providing growth opportunities for employees, is an honor and a privilege.”
Noting triumph over challenge, NJBIZ acknowledged innovation, discipline, and perseverance as just a few of GENEWIZ’s outstanding attributes. Schankweiler remarked, “Through trial and error, Liao and Sun built the company step by step [knowing the] importance of creating value.”
“This award is a wonderful reflection of GENEWIZ employees’ commitment to excellence,” continued Steve Sun, GENEWIZ Chairman & CEO. “It is invigorating to lead a diverse organization where employees’ quality of expertise and talent is so high. More importantly, the passion, energy, and excitement for advancing science exhibited on a daily basis is truly inspiring. We are very proud to accept this award, and to continue contributing to science, to the economy, and to our society.”
GENEWIZ, Inc. is a global contract research organization (CRO) specializing in DNA-based services, including DNA sequencing, gene synthesis, molecular biology, genomic, and GxP/CLIA regulatory-compliant services. The company leads the industry in research sequencing and outsourcing partnerships with pharmaceutical, clinical, biotechnology, academic, and government institutions.
Headquartered in South Plainfield, NJ, GENEWIZ, Inc. is a privately-held, global enterprise with locations in Washington, D.C. Metro, Boston, San Diego, Research Triangle Park, Beijing, China, Suzhou, China, and London, United Kingdom.